Cargando…

Saffron: A Multitask Neuroprotective Agent for Retinal Degenerative Diseases

Both age related macular degeneration (AMD) and light induced retinal damage share the common major role played by oxidative stress in the induction/progression of degenerative events. Light damaged (LD) rats have been widely used as a convenient model to gain insight into the mechanisms of degenera...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Marco, Stefano, Carnicelli, Veronica, Franceschini, Nicola, Di Paolo, Mattia, Piccardi, Marco, Bisti, Silvia, Falsini, Benedetto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681062/
https://www.ncbi.nlm.nih.gov/pubmed/31319529
http://dx.doi.org/10.3390/antiox8070224
_version_ 1783441645510852608
author Di Marco, Stefano
Carnicelli, Veronica
Franceschini, Nicola
Di Paolo, Mattia
Piccardi, Marco
Bisti, Silvia
Falsini, Benedetto
author_facet Di Marco, Stefano
Carnicelli, Veronica
Franceschini, Nicola
Di Paolo, Mattia
Piccardi, Marco
Bisti, Silvia
Falsini, Benedetto
author_sort Di Marco, Stefano
collection PubMed
description Both age related macular degeneration (AMD) and light induced retinal damage share the common major role played by oxidative stress in the induction/progression of degenerative events. Light damaged (LD) rats have been widely used as a convenient model to gain insight into the mechanisms of degenerative disease, to enucleate relevant steps and to test neuroprotectants. Among them, saffron has been shown to ameliorate degenerative processes and to regulate many genes and protective pathways. Saffron has been also tested in AMD patients. We extended our analysis to a possible additional effect regulated by saffron and compared in AMD patients a pure antioxidant treatment (Lutein/zeaxanthin) with saffron treatment. Methods: Animal model. Sprague-Dawley (SD) adult rats, raised at 5 lux, were exposed to 1000 lux for 24 h and then either immediately sacrificed or placed back at 5 lux for 7 days recovery period. A group of animals was treated with saffron. We performed in the animal model: (1) SDS-PAGE analysis; (2) Western Blotting (3) Enzyme activity assay (4) Immunolabelling; in AMD patients: a longitudinal open-label study 29 (±5) months in two groups of patients: lutein/zeaxanthin (19) and saffron (23) treated. Visual function was tested every 8 months by ERG recordings in addition to clinical examination. Results: Enzymatic activity of MMP-3 is reduced in LD saffron treated retinas and is comparable to control as it is MMP-3 expression. LD treated retinas do not present “rosettes” and microglia activation and migration is highly reduced. Visual function remains stable in saffron treated AMD patients while deteriorates in the lutein/zeaxanthin group. Conclusion: Our results provide evidence of an additional way of action of saffron treatment confirming the complex nature of neuroprotective activities of its chemical components. Accordingly, long term follow-up in AMD patients reveals an added value of saffron supplementation treatment compared to classical antioxidant protocol.
format Online
Article
Text
id pubmed-6681062
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66810622019-08-09 Saffron: A Multitask Neuroprotective Agent for Retinal Degenerative Diseases Di Marco, Stefano Carnicelli, Veronica Franceschini, Nicola Di Paolo, Mattia Piccardi, Marco Bisti, Silvia Falsini, Benedetto Antioxidants (Basel) Article Both age related macular degeneration (AMD) and light induced retinal damage share the common major role played by oxidative stress in the induction/progression of degenerative events. Light damaged (LD) rats have been widely used as a convenient model to gain insight into the mechanisms of degenerative disease, to enucleate relevant steps and to test neuroprotectants. Among them, saffron has been shown to ameliorate degenerative processes and to regulate many genes and protective pathways. Saffron has been also tested in AMD patients. We extended our analysis to a possible additional effect regulated by saffron and compared in AMD patients a pure antioxidant treatment (Lutein/zeaxanthin) with saffron treatment. Methods: Animal model. Sprague-Dawley (SD) adult rats, raised at 5 lux, were exposed to 1000 lux for 24 h and then either immediately sacrificed or placed back at 5 lux for 7 days recovery period. A group of animals was treated with saffron. We performed in the animal model: (1) SDS-PAGE analysis; (2) Western Blotting (3) Enzyme activity assay (4) Immunolabelling; in AMD patients: a longitudinal open-label study 29 (±5) months in two groups of patients: lutein/zeaxanthin (19) and saffron (23) treated. Visual function was tested every 8 months by ERG recordings in addition to clinical examination. Results: Enzymatic activity of MMP-3 is reduced in LD saffron treated retinas and is comparable to control as it is MMP-3 expression. LD treated retinas do not present “rosettes” and microglia activation and migration is highly reduced. Visual function remains stable in saffron treated AMD patients while deteriorates in the lutein/zeaxanthin group. Conclusion: Our results provide evidence of an additional way of action of saffron treatment confirming the complex nature of neuroprotective activities of its chemical components. Accordingly, long term follow-up in AMD patients reveals an added value of saffron supplementation treatment compared to classical antioxidant protocol. MDPI 2019-07-17 /pmc/articles/PMC6681062/ /pubmed/31319529 http://dx.doi.org/10.3390/antiox8070224 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Di Marco, Stefano
Carnicelli, Veronica
Franceschini, Nicola
Di Paolo, Mattia
Piccardi, Marco
Bisti, Silvia
Falsini, Benedetto
Saffron: A Multitask Neuroprotective Agent for Retinal Degenerative Diseases
title Saffron: A Multitask Neuroprotective Agent for Retinal Degenerative Diseases
title_full Saffron: A Multitask Neuroprotective Agent for Retinal Degenerative Diseases
title_fullStr Saffron: A Multitask Neuroprotective Agent for Retinal Degenerative Diseases
title_full_unstemmed Saffron: A Multitask Neuroprotective Agent for Retinal Degenerative Diseases
title_short Saffron: A Multitask Neuroprotective Agent for Retinal Degenerative Diseases
title_sort saffron: a multitask neuroprotective agent for retinal degenerative diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681062/
https://www.ncbi.nlm.nih.gov/pubmed/31319529
http://dx.doi.org/10.3390/antiox8070224
work_keys_str_mv AT dimarcostefano saffronamultitaskneuroprotectiveagentforretinaldegenerativediseases
AT carnicelliveronica saffronamultitaskneuroprotectiveagentforretinaldegenerativediseases
AT franceschininicola saffronamultitaskneuroprotectiveagentforretinaldegenerativediseases
AT dipaolomattia saffronamultitaskneuroprotectiveagentforretinaldegenerativediseases
AT piccardimarco saffronamultitaskneuroprotectiveagentforretinaldegenerativediseases
AT bistisilvia saffronamultitaskneuroprotectiveagentforretinaldegenerativediseases
AT falsinibenedetto saffronamultitaskneuroprotectiveagentforretinaldegenerativediseases